Stephen Cornelissen/LinkedIn
Feb 4, 2026, 08:05
Stephen Cornelissen Honors the Life-Saving Impact of Blood Donation on World Cancer Day
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”On World Cancer Day, I’m reminded that behind every diagnosis is a person and a story shaped by resilience, fear, hope, and the people who stand beside them.
Blood cancer patients are the largest users of donated blood in Australia.
More than a third of all whole blood donations support cancer treatment, helping patients stay strong enough to undergo chemotherapy and other intensive therapies.
These donations don’t treat the cancer itself, but they make treatment possible.
It highlights the vital role Australian Red Cross Lifeblood donors play in supporting patients through treatment.”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 15:56Anita Zaidi: Why Only 2% of Health Research and Development Goes to Women’s Conditions
-
Sep 21, 2026, 15:49Omid Khalafi: Gating Strategy and How Do We Decide Which Cells to Analyze
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime